Revolutionising cellular therapies for cancer and beyond

We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

World Ovarian Cancer Day – Insights from Board Advisor, Heather Hawkins

By Christine Filippis / May 8, 2025
Today on World Ovarian Cancer Day, we are proud to share the powerful story of Heather Hawkins - ovarian cancer...
Read More

Cartherics appoints new Board Chair and Non-Executive Director

By Christine Filippis / April 16, 2025
Cartherics appoints Prof. Bryan Williams as new Board Chair and Ms. Laurence Nore as Non-Executive Director Melbourne, Australia, 16 April...
Read More

Cartherics strengthens scientific and manufacturing team

By Christine Filippis / March 20, 2025
Cartherics is pleased to announce that it has made several strategic new appointments to enhance its scientific and manufacturing teams,...
Read More
1 2 3 64